Cubist Systematic Strategies’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.7M | Sell |
102,548
-141,438
| -58% | -$4.66M | 0.02% | 1163 |
|
|
2025
Q2 | $8.78M | Buy |
+243,986
| New | +$9.08M | 0.04% | 676 |
|
|
2024
Q3 | – | Sell |
-679,020
| Closed | -$14.8M | – | 3493 |
|
|
2024
Q2 | $12.1M | Sell |
679,020
-3,993
| -0.6% | -$63.7K | 0.08% | 326 |
|
|
2024
Q1 | $10.4M | Buy |
683,013
+610,280
| +839% | +$9.72M | 0.06% | 510 |
|
|
2023
Q4 | $1.24M | Sell |
72,733
-454,755
| -86% | -$5.29M | 0.01% | 1879 |
|
|
2023
Q3 | $4.41M | Buy |
527,488
+475,738
| +919% | +$6.63M | 0.03% | 836 |
|
|
2023
Q2 | $1.29M | Sell |
51,750
-86,464
| -63% | -$2.23M | 0.01% | 1801 |
|
|
2023
Q1 | $2.08M | Buy |
138,214
+103,773
| +301% | +$1.58M | 0.01% | 1648 |
|
|
2022
Q4 | $407K | Sell |
34,441
-136,352
| -80% | -$990K | ﹤0.01% | 3156 |
|
|
2022
Q3 | $1.01M | Buy |
170,793
+143,001
| +515% | +$938K | 0.01% | 2617 |
|
|
2022
Q2 | $118K | Sell |
27,792
-116,494
| -81% | -$727K | ﹤0.01% | 3912 |
|
|
2022
Q1 | $1.37M | Buy |
144,286
+122,129
| +551% | +$1.41M | 0.01% | 1780 |
|
|
2021
Q4 | $421K | Buy |
+22,157
| New | +$575K | ﹤0.01% | 2573 |
|
|
2021
Q3 | – | Sell |
-11,000
| Closed | -$427K | – | 3172 |
|
|
2021
Q2 | $427K | Buy |
11,000
+4,369
| +66% | +$172K | ﹤0.01% | 2107 |
|
|
2021
Q1 | $320K | Sell |
6,631
-16,800
| -72% | -$807K | ﹤0.01% | 2217 |
|
|
2020
Q4 | $1.22M | Buy |
+23,431
| New | +$792K | 0.02% | 1249 |
|
|
2020
Q2 | – | Sell |
-18,093
| Closed | -$178K | – | 2532 |
|
|
2020
Q1 | $178K | Sell |
18,093
-229,271
| -93% | -$2.9M | ﹤0.01% | 1780 |
|
|
2019
Q4 | $2.75M | Buy |
247,364
+238,722
| +2,762% | +$1.82M | 0.05% | 582 |
|
|
2019
Q3 | $49K | Buy |
8,642
+7,342
| +565% | +$51.2K | ﹤0.01% | 2043 |
|
|
2019
Q2 | $11K | Buy |
+1,300
| New | +$9.83K | ﹤0.01% | 2404 |
|
|
2018
Q4 | – | Sell |
-26,598
| Closed | -$149K | – | 2281 |
|
|
2018
Q3 | $149K | Buy |
+26,598
| New | +$304K | 0.01% | 1502 |
|
|
2018
Q2 | – | Sell |
-12,376
| Closed | -$176K | – | 2044 |
|
|
2018
Q1 | $176K | Buy |
+12,376
| New | +$158K | 0.01% | 1453 |
|
|
2017
Q1 | – | Sell |
-38,622
| Closed | -$180K | – | 1864 |
|
|
2016
Q4 | $180K | Buy |
+38,622
| New | +$226K | 0.01% | 1303 |
|
|
2015
Q4 | – | Sell |
-11,708
| Closed | -$118K | – | 1943 |
|
|
2015
Q3 | $118K | Buy |
+11,708
| New | +$174K | 0.01% | 1594 |
|
|
2015
Q1 | – | Sell |
-442
| Closed | -$7K | – | 2081 |
|
|
2014
Q4 | $7K | Buy |
+442
| New | +$5.76K | ﹤0.01% | 1836 |
|
Other funds holding TGTX
SCM
HRCM
Cubist Systematic Strategies's TGTX Position: Q3 2025 in Review
Cubist Systematic Strategies reduced its TG Therapeutics (TGTX) stake by 58% in Q3 2025, selling an estimated $4.66M and leaving 102,548 shares worth $3.7M. The position accounts for 0.02% of the portfolio, ranked #1163.
Cubist Systematic Strategies first reported a position in TGTX in Q4 2014 and has held it in 25 quarters since. The position peaked at $12.1M in Q2 2024. 354 funds tracked by Wall St. Rank hold TGTX as of Q3 2025.
- Cubist Systematic Strategies held 102,548 shares of TG Therapeutics worth $3.7M as of Q3 2025.
- Cubist Systematic Strategies sold 141,438 TG Therapeutics shares in Q3 2025, an estimated $4.66M.
- TG Therapeutics made up 0.02% of Cubist Systematic Strategies's portfolio in Q3 2025, its #1163 holding.
- Cubist Systematic Strategies first reported a position in TG Therapeutics in Q4 2014 and has held it in 25 quarters since.
- Cubist Systematic Strategies's TG Therapeutics position peaked at $12.1M in Q2 2024.
- 354 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2025.
Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.